Literature DB >> 16435572

Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry.

Y Du1, Q Zhang, G G Chen, P Wei, C Y Tu.   

Abstract

Pharmacokinetics of Astragaloside IV (AGS-IV) in rats was studied by high performance liquid chromatography coupled with tandem mass spectrometry. The concentration in plasma was determined after i.v. administration of 1, 2, 4 mg/kg and p.o. administration of 20 mg/kg of AGS-IV. The AUC were linearly correlated to doses. Recoveries of AGS-IV in bile, urine and feces were also analyzed following i.v. dose of 2 mg/kg. Cumulative recovery of AGS-IV in bile reached 30.8% in 24h. Cumulative recovery of AGS-IV in urine and feces was 52.14%, which indicates that about 50% of AGS-IV was metabolized in vivo. The bioavailability of AGS-IV after p.o. administration was found to be 3.66%. These findings provide useful information for the research and development of AGS-IV and other potential agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435572     DOI: 10.1007/BF03190631

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  Determination of astragaloside IV in Radix astragali (Astragalus membranaceus var. monghulicus) using high-performance liquid chromatography with evaporative light-scattering detection.

Authors:  W Li; J F Fitzloff
Journal:  J Chromatogr Sci       Date:  2001-11       Impact factor: 1.618

2.  Determination of Astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry.

Authors:  Yongchuan Gu; Guangji Wang; J Paul Fawcett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-03-05       Impact factor: 3.205

3.  Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry.

Authors:  Weidong Zhang; Chuan Zhang; Runhui Liu; Huiliang Li; Jintao Zhang; Chen Mao; Chunlin Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-08-05       Impact factor: 3.205

4.  Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice.

Authors:  Yan-Ping Wang; Xiao-Yu Li; Chun-Qing Song; Zhi-Bi Hu
Journal:  Acta Pharmacol Sin       Date:  2002-03       Impact factor: 6.150

5.  A precolumn derivatization high-performance liquid chromatographic method with improved sensitivity and specificity for the determination of astragaloside IV in Radix Astragali.

Authors:  M Yao; Y Qi; K Bi; X Wang; X Luo; C Che
Journal:  J Chromatogr Sci       Date:  2000-08       Impact factor: 1.618

6.  Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.

Authors:  Yumin Luo; Zhen Qin; Zhen Hong; Xinmin Zhang; Ding Ding; Jian-Hui Fu; Wei-Dong Zhang; Jun Chen
Journal:  Neurosci Lett       Date:  2004-06-17       Impact factor: 3.046

  6 in total
  5 in total

1.  Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102).

Authors:  Lin-Sen Qing; Ting-Bo Chen; Wen-Xia Sun; Li Chen; Pei Luo; Zhi-Feng Zhang; Li-Sheng Ding
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.441

2.  Pharmacokinetics of astragaloside iv in beagle dogs.

Authors:  Qi Zhang; Ling-Ling Zhu; Guo-Guang Chen; Yu Du
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Apr-Jun       Impact factor: 2.441

3.  Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.

Authors:  Wei-Jian Zhang; Balz Frei
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

4.  Astragaloside IV Exerts Cognitive Benefits and Promotes Hippocampal Neurogenesis in Stroke Mice by Downregulating Interleukin-17 Expression via Wnt Pathway.

Authors:  Li Sun; Heming Zhang; Wen Wang; Zhiyang Chen; Shuang Wang; Jiangjing Li; Guangyao Li; Changjun Gao; Xude Sun
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

5.  Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism.

Authors:  Huan Zhang; Jiaying Song; Huizhen Dai; Yanchao Liu; Lili Wang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.